Safety and Efficacy Study of Artesunate and Mefloquin in Children With Uncomplicated Malaria

PHASE4CompletedINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

December 31, 2007

Study Completion Date

March 31, 2009

Conditions

Malaria

Interventions

DRUG

artesunate and mefloquine

artesunate (50 mg/day) and mefloquine (125 mg/day) fixed dose formulation (stick pack) once daily for 3 consecutive days, orally

Trial Locations (1)

Centre Mère et Enfant, Fondation Chantal Biya, Yaoundé

All Listed Sponsors

collaborator

Centre Mère et Enfant de la Fondation Chantal Biya

OTHER

lead

Mepha Ltd.

INDUSTRY

NCT00978172 - Safety and Efficacy Study of Artesunate and Mefloquin in Children With Uncomplicated Malaria | Biotech Hunter | Biotech Hunter